Zhuanglin Li

发表

Development of novel anti‐CD19 antibody‐drug conjugates for B‐cell lymphoma treatment

Jianmin Fang, Lina Liu, Xuejing Yao, 2018, International immunopharmacology.

A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity

L. Lou, Dong Li, Jianmin Fang, 2015, Breast Cancer Research and Treatment.

Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer

Jianmin Fang, Wenting Luo, Xuejing Yao, 2019, Cancer Chemotherapy and Pharmacology.

A fusion fragment from Flt-1 and KDR, acted as VEGF decoy receptor and exhibited anti-tumor function

Guanjun Chen, Weifeng Liu, X. Yao, 2010, Biotechnology Letters.

Delivery of siRNA targeting HIF-1α loaded chitosan modified D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin

Lin Mei, Yuhan Chen, Xiaowei Zeng, 2016 .

RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2

Lin Mei, Xiaowei Zeng, Zihuang Li, 2017, OncoTargets and therapy.

Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study

G. Royle, S. Manolopoulos, Ying Zhang, 2023, The British journal of radiology.

Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy

Jianmin Fang, Wenting Luo, Xuejing Yao, 2019, Targeted Oncology.

Structural Characterization of RC28-E, a Recombinant Fusion Protein With Dual Targets on VEGF and FGF2

Xuejing Yao, Zhuanglin Li, Wenlong Sun, 2022, Natural Product Communications.